Food Allergy

>

Latest News

R. Sharon Chinthrajah, MD | Credit: Stanford Medicine
OUtMATCH: Omalizumab Proves Utility in Multiple Food Allergies for Pediatric, Adult Patients

February 25th 2024

Omalizumab, the only FDA-approved treatment for multiple food allergies, demonstrated significant efficacy in the OUtMATCH trial, with 67% achieving the primary outcome compared to 7% in the placebo group.

Children with Food Allergies May Benefit from Home Reintroduction of FPIES
Children with Food Allergies May Benefit from Home Reintroduction of FPIES

February 22nd 2024

Baked Milk Oral Immunotherapy Leads to Improvements for Patients with Cow’s Milk Allergy
Baked Milk Oral Immunotherapy Leads to Improvements for Patients with Cow’s Milk Allergy

February 21st 2024

FDA Approves Omalizumab as First Treatment of 1 or More Food Allergies for Children, Adults
FDA Approves Omalizumab as First Treatment of 1 or More Food Allergies for Children, Adults

February 16th 2024

Egg Consumption Shown to Impact Predictive Value of Diagnostic Allergy Assessments
Egg Consumption Shown to Impact Predictive Value of Diagnostic Allergy Assessments

January 23rd 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.